ATE125541T1 - Reine kristalline form von rifapentin. - Google Patents

Reine kristalline form von rifapentin.

Info

Publication number
ATE125541T1
ATE125541T1 AT91911451T AT91911451T ATE125541T1 AT E125541 T1 ATE125541 T1 AT E125541T1 AT 91911451 T AT91911451 T AT 91911451T AT 91911451 T AT91911451 T AT 91911451T AT E125541 T1 ATE125541 T1 AT E125541T1
Authority
AT
Austria
Prior art keywords
crystalline form
pure crystalline
rifapentin
new pure
rifapentine
Prior art date
Application number
AT91911451T
Other languages
English (en)
Inventor
Marino Nebuloni
Emilio Occelli
Bruno Cavalleri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE125541T1 publication Critical patent/ATE125541T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
AT91911451T 1990-06-29 1991-06-05 Reine kristalline form von rifapentin. ATE125541T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90112458 1990-06-29

Publications (1)

Publication Number Publication Date
ATE125541T1 true ATE125541T1 (de) 1995-08-15

Family

ID=8204159

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911451T ATE125541T1 (de) 1990-06-29 1991-06-05 Reine kristalline form von rifapentin.

Country Status (13)

Country Link
EP (1) EP0536197B1 (de)
JP (1) JP3350861B2 (de)
KR (1) KR0170000B1 (de)
AT (1) ATE125541T1 (de)
BG (1) BG60980B2 (de)
CA (1) CA2082809C (de)
DE (1) DE69111607T2 (de)
DK (1) DK0536197T3 (de)
ES (1) ES2075454T3 (de)
HK (1) HK1005454A1 (de)
HU (1) HU211168A9 (de)
IE (1) IE68687B1 (de)
WO (1) WO1992000302A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1279898B1 (de) 2001-07-26 2008-09-10 ALSTOM Technology Ltd Vormischbrenner mit hoher Flammenstabilität
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7262236B2 (en) 2004-04-26 2007-08-28 Milliken & Company Acetal-based compositions
ES2522895T3 (es) 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
WO2011080691A1 (en) 2009-12-28 2011-07-07 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
IT1397107B1 (it) * 2009-12-28 2012-12-28 Lavagna Nuovo metodo per la preparazione di antibiotici in stato amorfo e prodotti ottenuti utilizzando detto metodo.
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CN102079749B (zh) * 2010-11-25 2012-07-04 河北欣港药业有限公司 利福平原料药≤0.3g/ml及≥0.8g/ml密度规格的生产方法
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
CN103772413B (zh) * 2014-02-07 2016-01-20 天津大学 一种利福平ⅱ晶型的制备方法
WO2022225384A1 (es) * 2021-04-21 2022-10-27 Interquim, S.A. De C.V. Proceso de obtención de rifapentina. con una nueva forma cristalina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides

Also Published As

Publication number Publication date
HU211168A9 (en) 1995-11-28
DE69111607D1 (de) 1995-08-31
DK0536197T3 (da) 1995-11-13
KR930701448A (ko) 1993-06-11
EP0536197A1 (de) 1993-04-14
JP3350861B2 (ja) 2002-11-25
DE69111607T2 (de) 1995-12-21
BG60980B2 (bg) 1996-07-31
IE912266A1 (en) 1992-01-01
HK1005454A1 (en) 1999-01-08
CA2082809C (en) 1995-10-17
KR0170000B1 (ko) 1999-02-01
ES2075454T3 (es) 1995-10-01
WO1992000302A1 (en) 1992-01-09
JPH05507690A (ja) 1993-11-04
EP0536197B1 (de) 1995-07-26
IE68687B1 (en) 1996-07-10

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
ATE269290T1 (de) Benzoylderivate
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
ATE125541T1 (de) Reine kristalline form von rifapentin.
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DK0487319T3 (da) Hidtil ukendt heptamethylindanforbindelse
FR2687154B1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
FI923751A (fi) Hexahydrobenso/f/kinolinoner
FR2601021B2 (fr) Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
SE9004169D0 (sv) Anvaendning av farmaceutiska och kosmetiska kompositioner, innehaallande 1,8-dihydroxi-10-fenyl-9-antron som verksam bestaandsdel
ATE157959T1 (de) Indanderivate
DE3762854D1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
IT1303556B1 (it) Procedimento di preparazione di composti del tipoarilamminoalchilidenemalonati.
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time